Hims & Hers vs System Labs
Two GLP-1 desks, one scoreboard. We put Hims & Hers and System Labs head-to-head on the published Brief Score — the same six factors, scored the same way.
Hims & Hers
FDA warning letter, September 2025 — issued to Hims & Hers Health, Inc. dba Hims. See the FDA's warning letter database.
The verdict
Hims & Hers takes this head-to-head.
Hims & Hers scores 85 to 59 on our six-factor Brief Score — Mass-market, app-first weight program with nationwide reach — watch the compounded-supply headlines.
That doesn't make System Labs a bad call — it's best for readers who want one predictable tirzepatide bill they can cancel next month, and who will read the "/first mo." on the $99 before budgeting around it — not readers who came for semaglutide, or who need to confirm their state before starting an intake. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Hims & Hers | System Labs | |
|---|---|---|
| Brief Score | 85/100 (B) | 59/100 (C) |
| Semaglutide | $199/mo | Not offered — no semaglutide is sold here at any price |
| Tirzepatide | Not disclosed | $179/mo flat, month-to-month, the same at every dose — the $99 beside it is a first-month intro rate, not the ongoing one |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Risingprice rising | Newnew to the tracker, no prior reading |
Hims & Hers: App-first reach is nationwide, but compounded supply has drawn industry-wide scrutiny.
System Labs: First reading, 8 August 2026. One rate, one cadence: $179 a month, flat, month-to-month, identical at every dose — the FAQ commits to it in those words and the buy box sells a single "Monthly Supply (All doses)" line. No three-, six- or twelve-month rung exists, so there is no prepay figure here to mistake for a monthly one. The $99 printed beside it is a first-month intro rate, labeled "/first mo." on the page and flagged as an intro in the lander's own commerce data; month two is $179. Tirzepatide only — no semaglutide is sold at any price.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.